Study S000622

Nanjing First Hospital, Nanjing Medical University

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05553093
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: RECRUITING
Enrollment: 150
Start: 2022-03-15
Primary completion: 2023-12-31
Lead sponsor: Nanjing First Hospital, Nanjing Medical University
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG:Tirzepatide; DRUG:Insulin Glargine
Results posted: FALSE

Registered primary outcomes

blood sugar changes [40 weeks]
blood lipid changes [40 weeks]
Brain function [40 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.